More than 1,000 already committed to WoHX - see who's in the room

Boston, MA -- November:  As healthcare organizations decide where to invest their time, budget, and attention, one question matters more than almost any other:

Who will actually be in the room?

With Women's HealthX now just weeks away, the answer is becoming increasingly clear. More than 1,000 healthcare leaders and professionals are confirmed to attend, bringing together health plans, health systems and providers, employers, life sciences organizations, government, research institutions, and healthcare innovators.

And the numbers tell an important story about who that audience actually is.

Please note: this information is up to date as of November 10 2026 and will continue to change ahead of Women's HealthX on December 3-4.

A room full of decision-makers

Current attendee data shows:

• Nearly half are Director level or above
• 20% are C-suite executives or founders
• 23% are Directors or Department Heads
• 6% are Vice Presidents or Global Leaders
• See who's attending

In other words, almost half of the confirmed audience holds Director-level-or-above positions, putting many of the conversations at Women's HealthX directly in front of the people responsible for strategy, investment and change across healthcare.

More than 7 in 10 attendees are from the buyer and end-user community

Perhaps the most striking figure in the latest attendee data is the composition of the audience itself.

72% of confirmed attendees represent the buyer and end-user community, compared with just 28% from solution providers. That equates to an approximate 7:1 industry professionals to solution provider ratio.

For attendees, it means a room overwhelmingly made up of professionals working across healthcare delivery, funding, research, life sciences, workforce strategy and policy.

For partners and solution providers, it means something equally important: access to an audience principally made up of the organizations they want to understand, meet and work with.

See who's already attending.

A cross-sector conversation

Women's HealthX has been designed to bring together stakeholders who rarely have the opportunity to engage with each other in the same room.

Confirmed faculty and attendees include representatives from:

• Sanofi
• Novartis
• Boston University
• Biogen
• Organon
• Northeastern University
• Beth Israel Deaconess Medical Center
• Tufts Medical Center
• Brigham and Women's Hospital
• Mass General Brigham
• Humana
• Pfizer
• Blue Cross Blue Shield of Massachusetts
• Harvard Medical School
• CVS Health
• Point32Health

and many more.

Together, these organizations bring perspectives spanning healthcare delivery, reimbursement, research, life sciences, workforce strategy, innovation, and women's health.

Why it matters

The biggest challenges in women's health cannot be solved by any one stakeholder group acting alone.

Whether the focus is maternal health, menopause, chronic disease, workforce wellbeing, access, evidence generation, or care delivery, progress depends on collaboration across the healthcare ecosystem.

Women's HealthX has been built to facilitate exactly those conversations. With more than 1,000 attendees already confirmed, nearly half at Director level or above, and more than 7 in 10 drawn from the buyer and end-user community, the event is bringing together a substantial cross-functional audience focused on turning progress in women's health into practice.